Anthoxanthum odoratum

DB14163ApprovedAllergenics

Anthoxanthum odoratum is an extract from Anthoxanthum odoratum used in allergy testing.

Primary indication
Anthoxanthum odoratum is an allergen extract included in an allergenic testing product called ORALAIR.Curator reviewed · 2 structured indications
First approval
Canada, 2000 · United States, 1975
Also known as
Anthoxanthum alpinum whole · Anthoxanthum asperum whole · Anthoxanthum maderense whole · Anthoxanthum nebrodense whole · Anthoxanthum odoratum whole

Resolves to

Compound
UNIIYMW1K70E4Q
Clinical / RWD
RxNorm1319268

What you can answer from here — as of May 03, 2025

2Structured indicationsCondition, population, route and combination as fields, not prose
Sign in
13Marketed productsAcross 4 countries and 4 labellers
Sign in
1+ReferenceStructured and connected to the statements they support
Sign in

Which other approved drugs treat the same conditions as Anthoxanthum odoratum, and which companies have late-stage candidates in those indications?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In